Neil Peterman is a Principal Scientist in the Computational Biology team at Foundation Medicine, where he develops innovative diagnostic tools for cancer care. His work focuses on leveraging next-generation sequencing and robust datasets. He holds a PhD from Harvard University and a Masters degree from the University of Pennsylvania.
Neil is passionate about the patient impact of his work, stating that a clear purpose creates a culture built on doing something "truly powerful and serious. "
He has filed several patents related to liquid biopsy technology developed during his roles at Foundation Medicine and Lexent Bio.